Early detection of invasive lung cancer and multiorgan metastasis by a collagen-targeted protein MRI contrast agent
This approach offers a radiation-free tool for early diagnosis, staging, and monitoring in LUAD using LKB1/STK11 inactivation, which alters collagen via focal adhesion kinase activation, and develops hProCA32, a protein MRI contrast agent targeting collagen I.
Dong-Jun Li, Oluwabukola S. Bamishaye, Sandi Li et al.
· Science Advances · 1 citation